The treatment of psychological and behavioral symptoms in dementia;Die therapie nicht-kognitiver störungen bei demenzkranken mit neuroleptika

Zeitschrift fur Psychiatrie, Psychologie und Psychotherapie

Volumn 56, Issue 1, 2008, Pages 33-37

  Ibach, Bernd ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b JANSSEN CILAG GMBH   (Germany)

Author keywords

Antipsychotics; Comorbidity; Dementia; Drug drug interactions

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; BEHAVIOR; CLINICAL FEATURE; DEMENTIA; DRUG USE; ELDERLY CARE; HUMAN; PSYCHOSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 38949108017     PISSN: 16614747     EISSN: None     Source Type: Journal    
DOI: 10.1024/1661-4747.56.1.33     Document Type: Article

References (14)

1. Allain, H., Dautzenberg, P. H., Maurer, K., Schuck, S., Bonhomme, D. & Gerard, D. (2000). Double-blind study of tia-pride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment. Psychopharmacology (Berlin), 148, 361-366.
2. De Deyn, P. P., Rabheru, K., Rasmussen, A., Bocksberger, J. P., Dautzenberg, P. L., Eriksson, S. et al. (1999). A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology, 53, 946-955.
3. Fossey, J., Ballard, C., Juszczak, E., James, I., Alder, N., Jacoby, R. et al. (2006). Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: Cluster randomised trial. British Medical Journal, 332, 756-761.
4. Gill, S. S., Rochon, P. A., Herrmann, N., Lee, P. E., Sykora, K., Gunraj, N. et al. (2005). Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study. British Medical Journal, 330, 445.
5. Livingston, G., Walker, A. E., Katona, C. L. & Cooper, C. (2007). Antipsychotics and cognitive decline in Alzheimer's disease: The LASER-Alzheimer's disease longitudinal study. Journal of Neurology, Neurosurgery and Psychiatry, 78, 25-29.
6. Lopez, O. L., Becker, J. T., Wisniewski, S., Saxton, J., Kaufer, D. I. & DeKosky, S. T. (2002). Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 72, 310-314.
7. Lopez, O. L., Becker, J. T., Saxton, J., Sweet, R. A., Klunk, W. & DeKosky, S. T. (2005). Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by Cholinesterase inhibition. Journal of the American Geriatric Society, 53, 83-87.
8. Mintzer, J., Greenspan, A., Caers, I., Van, H. I., Kushner, S., Weiner, M. et al. (2006). Risperidone in the treatment of psychosis of Alzheimer disease: Results from a prospective clinical trial. American Journal of Geriatric Psychiatry, 14, 280-291.
9. Schneider, L. S., Dagerman, K. S. Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association, 294, 1934-1943.
10. Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail, M. S. et al. (2006a). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525-1538.
11. Schneider, L. S., Dagerman, K. & Insel, P. S. (2006b). Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191-210.
12. Spector, A., Thorgrimsen, L., Woods, B., Royan, L., Davies, S., Butterworth, M. et al. (2003). Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: Randomised controlled trial. British Journal of Psychiatry, 183, 248-254.
13. Suh, G. H., Son, H. G., Ju, Y. S., Jcho, K. H., Yeon, B. K., Shin, Y. M. et al. (2004). A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances. American Journal of Geriatric Psychiatry, 12, 509-516.
14. Tariot, P. N., Schneider, L., Katz, I. R., Mintzer, J. E., Street, J., Copenhaver, M. et al. (2006). Quetiapine treatment of psychosis associated with dementia: A double-blind, randomized, placebo-controlled clinical trial. American Journal of Geriatric Psychiatry, 14, 767-776.